Ignite Creation Date:
2025-12-24 @ 5:57 PM
Ignite Modification Date:
2026-02-22 @ 4:14 PM
Study NCT ID:
NCT00617968
Status:
COMPLETED
Last Update Posted:
2009-09-02
First Post:
2008-02-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
GETNA2 Neoadj. TAX+Femara vs Femara in g I/II Breast Cancer
Sponsor:
Sanofi
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
XRP6976D_2502
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Nathalie Billon/Study Director
Old Organization:
sanofi-aventis